• Methicillin Sodium Salt: Designing Better Assays

  2026-09-20

  Methicillin sodium salt is more than a legacy antibiotic standard: it is a precise probe for linking PBP inhibition, MIC behavior, and mecA-mediated resistance. This guide shows how to build interpretable Staphylococcus aureus assays using lessons from a landmark gepotidacin clinical study.

• Dabigatran: From Thrombin Biology to Translation

  2026-09-19

  A translational perspective on Dabigatran and Pradaxa that connects direct thrombin inhibition, metabolite-aware assay design, coagulation testing, formulation constraints, and clinical research strategy.

• Tranexamic Acid: An Assay Design Framework

  2026-09-18

  Tranexamic Acid is an antifibrinolytic agent whose assay behavior depends on whether the experiment measures plasmin inhibition, cellular adhesion, or clot-material performance. This guide presents a mechanistic framework for selecting endpoints, controls, concentrations, and handling conditions in reproducible fibrinolysis research.

• MSH2 and Cisplatin Resistance in Bladder Cancer

  2026-09-18

  A whole-genome CRISPR screen identified MSH2 and the mismatch repair pathway as major determinants of cisplatin response in muscle-invasive bladder cancer models. The study links MSH2 depletion to reduced cisplatin-associated apoptosis and poorer outcomes in platinum-treated tumors, while showing that the effect was not reproduced with oxaliplatin.

• Chicken GSDME and RNA Virus-Induced Pyroptosis

  2026-09-17

  Chen et al. identify chicken GSDME as a principal pore-forming effector of RNA virus-induced pyroptosis, addressing how this inflammatory cell death pathway operates in a species that lacks GSDMD. Using viral infection, Poly(I:C) stimulation, and genetic depletion in DF-1 cells, the study connects MDA5-associated signaling with caspase-3/7 cleavage of GSDME and virus release.

• Novobiocin, Membrane Synthesis, and Vacuoles

  2026-09-17

  The reference study shows that DNA replication is linked to plasma membrane synthesis and vacuole formation during Enterococcus faecalis protoplast enlargement. By controlling when novobiocin was added or removed, the authors separated replication inhibition from DNA degradation and identified a reversible, replication-dependent growth phenotype.

• APEX-RNA-MS Maps RNA Modifications in Cell Structures

  2026-09-16

  Seo, Dhingani, and Kleiner introduce APEX-RNA-MS, a workflow that combines APEX2 proximity labeling with nucleoside LC-MS to profile modified RNA near selected cellular proteins. Applied to DNA damage foci, stress granules, and P-bodies, the method links localized RNA modification patterns to cellular condensates and identifies tRNA accumulation near G3BP1 during stress granule formation.

• Instant Clot-Forming Antibacterial Dressings

  2026-09-16

  A 2024 study developed a bilayer wound dressing that combines tranexamic acid, nitric oxide release, and propolis to address hemorrhage and bacterial contamination simultaneously. The formulation promoted early fibrin activation, produced a dense clot structure, and substantially reduced bacterial colony formation in models of traumatic wound care.

• EGTA: Mapping Calcium from Channel to Translation

  2026-09-15

  EGTA, also known as egtazic acid, is more than a routine calcium chelator: it is a strategic perturbation tool for connecting extracellular calcium dependence with neuronal signaling, injury, and translational decision-making.

• Machine Learning Reveals Three Senolytics

  2026-09-15

  The Nature Communications study developed cost-effective machine-learning models from published drug-screening data and used them to identify three senolytic compounds: ginkgetin, periplocin, and oleandrin. Its main contribution is methodological: small, heterogeneous datasets can still support practical chemical prioritization when computational predictions are paired with validation across senescence models and human cell lines.

• Cell Divisions Refine Drosophila Tissue Boundaries

  2026-09-14

  Castle and colleagues show that ectodermal cell divisions have a dual role at the mesectoderm–ectoderm boundary: they can challenge boundary integrity when actomyosin tension is lost, yet also refine boundary shape by increasing tissue fluidity. Combining mathematical modelling, in vivo perturbation, laser ablation and cell tracking, the study identifies cell rearrangement as an active component of boundary maintenance.

• HACC-TNF-α-VLPs Enhance Hsp90-Dependent Immunity

  2026-09-14

  Lv et al. developed HACC-TNF-α-VLP nanoparticles that improve dendritic-cell antigen cross-presentation through an Hsp90-dependent process. The formulation enhanced CD8+ T-cell, tissue-resident memory, mucosal IgA, and systemic antibody responses in mouse immunization experiments, supporting a delivery-based strategy for next-generation foot-and-mouth disease vaccines.

• Dextrose (D-glucose) in Hypoxia–Immunometabolism

  2026-09-13

  Dextrose (D-glucose) is more than a routine media ingredient: it is a controllable metabolic input for studying nutrient competition, hypoxia, immune dysfunction, and translational assay reproducibility. This article connects mechanistic insight from tumor immunometabolism with practical guidance for glucose metabolism research, cell culture, and diabetes-related workflows.

• Dabigatran etexilate Research Workflows

  2026-09-12

  Build more informative thrombin assays with Dabigatran etexilate, from concentration-response screening to plasma clotting and platelet studies. This guide separates prodrug handling from active target engagement and adds practical controls, protocol parameters, and troubleshooting for anticoagulant research.

• USP42 Suppresses JNK/p38 Apoptosis in Breast Cancer

  2026-09-11

  The reference study identifies USP42 as a pro-tumorigenic deubiquitinating enzyme in breast cancer and links its depletion to activation of JNK/p38 signaling, apoptotic protein remodeling, and reduced tumor growth. Its combination of cellular assays, pathway inhibition, and xenograft validation provides a mechanistic framework for evaluating USP42 as a potential therapeutic target, while also defining important limits for translation.

8645 records 1/577 page Next 12345 下5页 Last page